Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2011 063 489.5 |
96 | EP file number | EAKZ | 11 74 0491.3 |
86 | WO file number | WAKZ | PCT/US2011/023917 |
97 | EP publication number | EPN | 2533799 |
87 | WO publication number | WPN | 2011097571 |
54 | Designation/title | TI | VERFAHREN ZUR VERWENDUNG VON PROGESTOGEN ALS GLUCOCORTICOID-SENSIBILISIERER |
51 | IPC main class | ICM (ICMV) | A61K 38/22 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/573 (2006.01), A61P 29/00 (2006.01), A61P 11/06 (2006.01), A61P 11/00 (2006.01), A61P 37/00 (2006.01) |
22 | DE application date | DAT | Feb 7, 2011 |
96 | EP application date | EAT | Feb 7, 2011 |
86 | WO application date | WAT | Feb 7, 2011 |
43 | Date of first publication | OT | Aug 11, 2011 |
| Date of publication of grant | PET | Nov 20, 2019 |
71/73 | Applicant/owner | INH | Shenzhen Evergreen Therapeutics Co., Ltd., Shenzhen, Guangdong Province, CN |
72 | Inventor | IN | DU, Tao, Tom, North Potomac, MD 20878, US |
74 | Representative | VTR | Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB, 80339 München, DE |
| Address for service | | Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB, 80339 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201113021950 Feb 7, 2011
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 302325 P Feb 8, 2010
|
| Due date | FT FG | Feb 28, 2026 Annual fee for the 16th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002533799 Searchable text:
EP000002533799 Original document:
EP000002533799B1 Searchable text:
EP000002533799B1 Original document:
WO002011097571 Searchable text:
WO002011097571 |
43 | Date of first publication | EVT | Aug 11, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Feb 1, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 22, 2025 (Show all update days)(Hide all update days)- Feb 22, 2025
- Oct 22, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 11.08.2011: deleted
- Feb 28, 2024; Feb 24, 2023; Feb 26, 2022; Feb 25, 2021; Nov 4, 2020; Oct 8, 2020; Feb 29, 2020; Jan 15, 2020; Nov 20, 2019; Nov 14, 2019; Oct 31, 2019; Aug 16, 2019; Jun 13, 2019
- Historical data not available for this/these date(s)
- Feb 1, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 19, 2019 |
71/73 | Applicant/owner | INH | Shenzhen Evergreen Therapeutics Co., Ltd., Shenzhen, Guangdong Province, CN |
71/73 | Previous applicant/owner | INHF | Du, Tao Tom, North Potomac, MD, US, Prairie Pharmaceuticals, LLC, Bethesda, MD, US |